Supplementary financial information (pa e q324 finsupp)
Financial and Operating Results Supplementary Financial Information
SUPPLEMENTARY FINANCIAL INFORMATION
TABLE OF CONTENTS
Page |
Page |
|||
Non-IFRS Financial Measures |
1 |
Investments |
||
Debt and Equity Securities |
32 |
|||
Financial Highlights |
2-3 |
Properties, Mortgages & Loans and Derivatives |
33 |
|
Consolidated Financial Statements |
Expenses |
|||
Statements of Operations |
4 |
Operating Expenses and Commissions |
34 |
|
Drivers of Earnings |
5-6 |
Interest Expense |
34 |
|
Underlying Net Income by Business Type |
5 |
|||
Statements of Financial Position |
7 |
Financial Strength and Capital Adequacy |
||
Statements of Equity |
8 |
Financial Strength and Debt Ratings |
35 |
|
LICAT Ratio - |
9 |
|||
Contractual Service Margin Movement Analysis |
10 |
General Information |
36 |
|
Segmented Results (Business Groups & Associated Business Units) |
Appendix |
|||
Asset Management |
11 |
Net Income Reconciliations |
37-40 |
|
MFS |
12 |
MFS Reconciliations |
41 |
|
SLC Management |
13-14 |
Asset Management Reported Net Income Reconciliation |
42 |
|
|
15-17 |
SLC Management Reported Net Income Reconciliation |
43 |
|
Canada Business Unit Summary |
18 |
Diluted Earnings Per Share Reconciliation |
44 |
|
|
19-24 |
Drivers of Earnings Reconciliations |
45-49 |
|
|
25 |
Additional Non-IFRS Financial Measures Glossary |
50-51 |
|
|
26-28 |
Reporting Refinements |
51 |
|
Asia Business Unit Summary |
29 |
Understanding the Drivers of Earnings |
52-53 |
|
Corporate |
30-31 |
Note to Readers: Restated Results on Adoption of IFRS 17 and IFRS 9
Basis of Presentation
All amounts in this document are presented in millions of Canadian dollars unless otherwise indicated. We prepare our unaudited Interim Consolidated Financial Statements using International Financial Reporting Standards ("IFRS"), the accounting requirements of the Office of the Superintendent
This document and the Q3'24 MD&A contain certain amounts that are presented on a net basis to reflect how the business is managed, compared to a gross basis in the Consolidated Financial Statements. Examples include:
- Within the
DOE : i) Net investment result and Other expenses of the Asset Management operating segment are combined with Fee Income to report the net contribution to earnings; ii) Income for fee-based businesses is reported net of the associated expenses; iii) Carried interest in SLC Management excludes the carried interest that Sun Life does not participate in economically, and nets the non-controlling interest ("NCI") against fee income and expenses of consolidated funds; iv) Net investment results include assets returns net of the crediting rate for investment contract liabilities and the unwinding of and changes in the discount rate for insurance contract liabilities; v) Earnings on surplus reflects net spread earned from investment strategies; vi) Earnings attributable to the participating account are excluded; and vii) Assumption changes and management actions ("ACMA") combines the amounts included in Net insurance service result and Net investment result. - Within the CSM Movement Analysis: i) The impacts of insurance contracts issued is presented net of reinsurance; ii) Impact of new business is presented net of acquisition expense gain/loss; and iii) Certain methodology changes are presented as an impact of change in assumptions, whereas the Consolidated Financial Statement presentation is a contract modification.
For more information on the
Constant Currency Measures
Constant currency measures are calculated using the average currency and period end rates, as appropriate, in effect in the comparable period. Constant currency measures are non-IFRS financial measures. See Section N. Non-IFRS Financial Measures, 3. Additional Non-IFRS Financial Measures of the Company's Q3'24 MD&A.
Rounding
Amounts in this document may be impacted by rounding.
Adjustments
Acquisition, Integration and Restructuring
In Q3'24 amounts include
In Q2'24 amounts include DentaQuest integration costs of
In Q1'24 amounts include DentaQuest integration costs of
In Q4'23, amounts include DentaQuest integration costs of
In Q3'23, amounts include DentaQuest integration costs of
In Q2'23, amounts include DentaQuest integration costs of
In Q1'23, amounts include DentaQuest integration costs of
In Q4'22, amounts include DentaQuest integration costs of
In Q3'22, amounts include DentaQuest integration costs of
Other
Q2'24: Amounts include a tax adjustment related to Pillar Two legislation of
Q1'24: Amounts include a gain relating to the early termination of a distribution agreement in Asset Management.
Q4'23: On
Q4'22: On
Q3'22: In
ii
Non-IFRS Financial Measures
Sun Life prepares annual and interim financial statements using IFRS. We report certain financial information that are not based on IFRS ("non-IFRS financial measures"), as we believe that these measures provide information that is useful to investors in understanding our performance and facilitate a comparison of our quarterly and full year results from period to period. These non-IFRS financial measures do not have any standardized meaning and may not be comparable with similar measures used by other companies. For certain non-IFRS financial measures, there are no directly comparable amounts under IFRS. These non-IFRS financial measures should not be viewed in isolation from or as alternatives to measures of financial performance determined in accordance with IFRS. Additional information concerning non-IFRS financial measures and, if applicable, reconciliations to the closest IFRS measures are available in the Company's annual and interim MD&A and the Supplementary Financial Information packages on www.sunlife.comunder Investors - Financial results and reports.
Underlying Net Income
Underlying net income is a non-IFRS financial measure that assists in understanding Sun Life's business performance by making certain adjustments to IFRS income. Underlying net income, along with common shareholders' net income (Reported net income), is used as a basis for management planning, and is also a key measure in our employee incentive compensation programs. This measure reflects management's view of the underlying business performance of the Company and long-term earnings potential. For example, due to the longer term nature of our individual protection businesses, market movements related to interest rates, equity markets and investment properties can have a significant impact on Reported net income in the reporting period. However, these impacts are not necessarily realized, and may never be realized, if markets move in the opposite direction in subsequent periods or, in the case of interest rates, the fixed income investment is held to maturity.
Underlying net income removes the impact of the following items from reported net income:
- Market-relatedimpacts reflecting the after-tax difference in actual versus expected market movements, including:
i. Net interest impact from risk-free rate, credit spread, and swap spread movements, reflecting accounting mismatches between assets and liabilities: -
- Differences arising from fair value changes(1) of fixed income assets (including derivatives) measured at Fair value through profit or loss ("FVTPL") supporting insurance contracts, compared to fair value changes of the liabilities(2);
- Fair value changes of fixed income assets (including derivatives) measured at FVTPL supporting our investment contract liability and surplus portfolios(3); and
- Tax-exemptinvestment income above or below expected long-term tax savings relating to our Canadian multi-national insurance operations.
-
- Non-fixedincome investments, where the weighted average expected retuis approximately 2% per quarter, including:
-
- Equity investments (including derivatives) supporting insurance contracts and surplus portfolios; and
- Investment properties supporting insurance contracts and surplus portfolios.
- ACMA - captures the impact of method and assumption changes, and management actions on insurance and reinsurance contracts.
- Other adjustments:
-
- Management's ownership of MFS(4) shares - this adjustment removes the change in fair value and other activity related to MFS common shares owned by management;
- Acquisition, integration, and restructuring - expense and income related to acquisition or disposal of a business. Also includes expenses related to restructuring activities;
- Intangible asset amortization - removes the amortization expense associated with finite life intangible assets arising from acquisitions or business combinations excluding amortization of software and distribution agreements; and
- Other - represents items that are unusual or exceptional in nature which management believes are not representative of the long-term performance of the Company.
Refer to Net Income Reconciliations - Pre-Tax and Post-Tax in the appendix of this document for the non-underlying adjustments from underlying net income to reported net income, as well as Section N. Non-IFRS Financial Measures, 2. Underlying Net Income and Underlying EPS and 4. Reconciliations of Select Non-IFRS Financial Measures of the Company's Q3'24 MD&A.
For more information about business types in Sun Life's operating segments/business groups, see the General Information section of this document and Section A. How We Report Our Results under the heading Underlying Net Income by Business Types of the Company's Q3'24 MD&A.
Underlying Diluted Earnings per Share ("EPS")
This measure is used in comparing the profitability across multiple periods and is calculated by dividing Underlying net income by weighted average common shares outstanding for diluted EPS, excluding the dilutive impact of convertible instruments. For additional information about the Underlying net income, see above. For additional information about the composition of the EPS, please refer to Note 13 of our Q3'24 Consolidated Financial Statements for the period ended
Drivers of Earnings ("DOE")
The
Contractual Service Margin ("CSM")
CSM represents a source of stored value for future insurance profits and qualifies as available capital for LICAT(5) purposes. CSM is a component of insurance contract liabilities. Refer to the Basis of Presentation section on page ii of this document for more information about certain amounts that are presented on a net basis to reflect how the business is managed, compared to a gross basis in the Consolidated Financial Statements.
Organic CSM Movement is comprised of the Impact of new insurance business, Expected movements from asset returns & locked-in rates, Insurance experience gains/losses, and CSM recognized for services provided.- Impact of new insurance business on CSM, also referred to as "new business CSM", represents growth from sales activity in the period, including individual protection sales (excluding joint ventures), and defined benefit solutions and segregated fund wealth sales in
Canada . New business CSM is presented net of acquisition expense gain/loss. - Expected movements from asset returns & locked-in rates applies to variable fee approach ("VFA") and general measurement approach ("GMA") contracts. For VFA contracts, this component of the CSM movement analysis is comprised of two factors: (i) the expected retuon underlying assets and (ii) the measurement of financial guarantees. The difference between actual and expected results are reported as the impact of markets. For GMA contracts, this component of the CSM includes the accretion of the CSM balance at locked-in rates, which refer to the term structure associated with locked-in discount rates, set when the insurance contract was sold or on transition to IFRS 17. Average locked-in rates increase with the passage of time on in-force business and new business added at current rates.
- Impact of markets & other includes the difference between actual and expected movement for VFA contracts for: (i) the retuon underlying assets and (ii) the measurement of financial guarantees. Also includes other amounts excluded from
Organic CSM Movement . - Insurance experience gains/losses represents the current period impacts of insurance experience, resulting in a change in future cash flows that adjust CSM.
- Impact of change in assumptions represents the future period impacts of changes in fulfilment cash flows that adjust CSM.
- For fixed income assets, Underlying net income includes credit experience from rating changes on assets measured at FVTPL, and the Expected credit loss ("ECL") impact for assets measured at Fair value through other comprehensive income ("FVOCI").
- Underlying net income is based on observable discount curves and exchange rates at the beginning of the period.
- Underlying net income for earnings on surplus includes realized gains (losses) on fixed income assets classified as FVOCI.
MFS Investment Management ("MFS").- Life Insurance Capital Adequacy Test ("LICAT") ratio. Our LICAT ratios are calculated in accordance with the OSFI-mandated guideline, Life Insurance Capital Adequacy Test.
1
FINANCIAL HIGHLIGHTS |
At and For the Quarter Ended |
At and For the Year |
|||||||||||
Ended |
|||||||||||||
(C$ millions, unless otherwise noted) |
Q3 2024 |
Q2 2024 |
Q1 2024 |
Q4 2023 |
Q3 2023 |
Q2 2023 |
Q1 2023 |
Q4 2022 |
Q3 2022 |
2023 |
2022 |
||
RESULTS |
|||||||||||||
Underlying Net Income by Segment (1) |
|||||||||||||
Asset Management |
1 |
344 |
307 |
282 |
331 |
330 |
296 |
282 |
324 |
298 |
1,239 |
1,238 |
|
|
2 |
375 |
402 |
310 |
350 |
338 |
372 |
316 |
265 |
293 |
1,376 |
1,063 |
|
|
3 |
219 |
204 |
189 |
253 |
185 |
215 |
237 |
230 |
227 |
890 |
698 |
|
|
4 |
170 |
179 |
177 |
143 |
166 |
150 |
141 |
135 |
153 |
600 |
539 |
|
Corporate |
5 |
(92) |
(92) |
(83) |
(94) |
(89) |
(113) |
(81) |
(62) |
(22) |
(377) |
(169) |
|
Total underlying net income (1) |
6 |
1,016 |
1,000 |
875 |
983 |
930 |
920 |
895 |
892 |
949 |
3,728 |
3,369 |
|
Reported Net Income - Common Shareholders by Segment |
|||||||||||||
Asset Management |
7 |
644 |
274 |
284 |
297 |
268 |
248 |
254 |
321 |
218 |
1,067 |
1,148 |
|
|
8 |
382 |
292 |
290 |
348 |
365 |
210 |
329 |
453 |
56 |
1,252 |
1,241 |
|
|
9 |
339 |
127 |
97 |
101 |
132 |
175 |
168 |
202 |
125 |
576 |
532 |
|
|
10 |
32 |
151 |
235 |
44 |
211 |
122 |
134 |
92 |
- |
511 |
210 |
|
Corporate |
11 |
(49) |
(198) |
(88) |
(41) |
(105) |
(95) |
(79) |
97 |
(288) |
(320) |
(260) |
|
Total reported net income - Common shareholders |
12 |
1,348 |
646 |
818 |
749 |
871 |
660 |
806 |
1,165 |
111 |
3,086 |
2,871 |
Profitability Measures |
|||||||||||
Basic earnings per common share ("EPS") |
|||||||||||
Reported |
13 |
2.33 |
1.11 |
1.40 |
1.28 |
1.49 |
1.12 |
1.37 |
1.99 |
0.19 |
5.27 |
Diluted EPS |
|||||||||||
Underlying (1) |
14 |
1.76 |
1.72 |
1.50 |
1.68 |
1.59 |
1.57 |
1.52 |
1.52 |
1.62 |
6.36 |
Reported |
15 |
2.33 |
1.11 |
1.40 |
1.28 |
1.48 |
1.12 |
1.37 |
1.98 |
0.19 |
5.26 |
4.90
5.75
4.89
Retuon equity ("ROE") - underlying (1) |
16 |
17.9% |
18.1% |
16.0% |
18.4% |
17.7% |
17.7% |
17.3% |
17.7% |
19.4% |
17.8% |
17.0% |
|
ROE - reported (1) |
17 |
23.8% |
11.7% |
15.0% |
14.0% |
16.6% |
12.7% |
15.6% |
23.2% |
2.3% |
14.7% |
14.5% |
|
Dividend per common share ($) |
18 |
0.81 |
0.81 |
0.78 |
0.78 |
0.75 |
0.75 |
0.72 |
0.72 |
0.69 |
3.00 |
2.76 |
|
Dividend payout ratio (1) |
|||||||||||||
Underlying (1) |
19 |
46% |
47% |
52% |
46% |
47% |
48% |
47% |
47% |
43% |
47% |
48% |
|
Reported (2) |
20 |
35% |
73% |
56% |
61% |
51% |
67% |
53% |
36% |
nm |
57% |
56% |
|
Dividend yield (1) |
21 |
4.5% |
4.7% |
4.4% |
4.7% |
4.5% |
4.5% |
4.4% |
4.8% |
4.7% |
4.5% |
4.4% |
|
Valuation Data |
|||||||||||||
Book value per common share |
22 |
39.88 |
37.70 |
37.41 |
36.51 |
35.91 |
34.86 |
35.34 |
34.60 |
33.33 |
36.51 |
34.60 |
|
Tangible book value per common share (1) |
23 |
18.81 |
16.80 |
16.68 |
16.01 |
15.51 |
15.20 |
15.36 |
14.79 |
13.15 |
16.01 |
14.79 |
|
Price-to-book value (times) |
24 |
1.97 |
1.78 |
1.98 |
1.88 |
1.85 |
1.98 |
1.79 |
1.82 |
1.65 |
1.88 |
1.82 |
|
Total market capitalization (TSX in $ billions) |
25 |
45.2 |
38.8 |
43.1 |
40.2 |
38.7 |
40.5 |
37.0 |
36.9 |
32.2 |
40.2 |
36.9 |
|
Common Share Information (SLF on TSX) |
|||||||||||||
High (intraday) |
26 |
78.85 |
73.89 |
74.94 |
70.82 |
70.11 |
69.18 |
69.09 |
64.64 |
62.44 |
70.82 |
74.22 |
|
Low (intraday) |
27 |
64.38 |
64.60 |
67.29 |
61.84 |
63.33 |
62.67 |
60.01 |
52.97 |
54.11 |
60.01 |
52.97 |
|
Close (end of period) |
28 |
78.45 |
67.08 |
73.91 |
68.72 |
66.27 |
69.06 |
63.14 |
62.85 |
54.93 |
68.72 |
62.85 |
|
Financial Strength |
|||||||||||||
SLF LICAT ratio (3) |
29 |
152% |
150% |
148% |
149% |
147% |
148% |
148% |
130% |
129% |
149% |
130% |
|
SLA LICAT ratio (3) |
30 |
147% |
142% |
142% |
141% |
138% |
139% |
144% |
127% |
123% |
141% |
127% |
|
Financial leverage ratio (1) |
31 |
20.4% |
22.6% |
21.1% |
21.5% |
21.8% |
23.3% |
23.2% |
25.1% |
26.4% |
21.5% |
25.1% |
|
Sales, Gross Flows and Net Flows (1) |
|||||||||||||
Wealth sales & asset management gross flows |
32 |
41,915 |
46,262 |
46,898 |
45,750 |
39,324 |
42,397 |
46,349 |
43,269 |
42,146 |
173,820 |
198,650 |
|
Net wealth sales & asset management net flows |
33 |
(17,217) |
(19,666) |
(9,990) |
(9,715) |
(9,122) |
(3,476) |
(1,772) |
(12,055) |
(8,105) |
(24,085) |
(20,471) |
|
Individual - Protection sales |
34 |
730 |
753 |
757 |
707 |
669 |
604 |
511 |
498 |
444 |
2,491 |
1,767 |
|
Group - Health & Protection sales (4) |
35 |
445 |
494 |
528 |
1,459 |
374 |
600 |
509 |
1,345 |
499 |
2,942 |
2,554 |
- Represents a non-IFRS financial measure. Refer to the Non-IFRS Financial Measures section on page 1 and the Additional Non-IFRS Financial Measures Glossary in the appendix of this document,or Section N. Non-IFRS Financial Measures of the Company's Q3'24 MD&A.
- Reported dividend payout ratio in Q3'22 is "nm" that is defined as not meaningful.
- Life Insurance Capital Adequacy Test ("LICAT") ratio. Our LICAT ratios are calculated in accordance with OSFI-mandated guideline, Life Insurance Capital Adequacy Test.
Sun Life Assurance Company of Canada ("SLA" or "Sun Life Assurance") isSLF Inc.'s principal operating life insurance subsidiary. - Effective Q4'23, prior period amounts related to sales in the
U.S. Dental segment have been restated to reflect new information.
2
FINANCIAL HIGHLIGHTS CONTINUED |
At and For the Quarter Ended |
At and For the Year |
||||||||||
Ended |
||||||||||||
Q3 2024 |
Q2 2024 |
Q1 2024 |
Q4 2023 |
Q3 2023 |
Q2 2023 |
Q1 2023 |
Q4 2022 |
Q3 2022 |
2023 |
2022 |
||
Number of Common Shares Outstanding (in millions) (1) |
||||||||||||
At beginning of period |
1 |
578.4 |
582.5 |
584.6 |
584.3 |
586.9 |
586.7 |
586.4 |
586.1 |
586.1 |
586.4 |
586.0 |
Common shares issued |
2 |
0.1 |
- |
0.3 |
0.3 |
0.2 |
0.2 |
0.3 |
0.3 |
- |
1.0 |
0.4 |
Common shares purchased and cancelled |
3 |
(2.0) |
(4.1) |
(2.4) |
- |
(2.8) |
- |
- |
- |
- |
(2.8) |
- |
At end of period |
4 |
576.5 |
578.4 |
582.5 |
584.6 |
584.3 |
586.9 |
586.7 |
586.4 |
586.1 |
584.6 |
586.4 |
Weighted average shares outstanding - basic |
5 |
578 |
581 |
584 |
584 |
586 |
587 |
587 |
586 |
586 |
586 |
586 |
Weighted average shares outstanding - diluted (2) |
6 |
581 |
584 |
587 |
587 |
589 |
590 |
590 |
590 |
589 |
589 |
589 |
Assets Under Management and Administration ("AUMA") (3) |
||||||||||||
General funds |
7 |
216,180 |
207,545 |
204,986 |
204,789 |
193,858 |
196,575 |
201,792 |
198,316 |
198,181 |
204,789 |
198,316 |
Segregated funds |
8 |
145,072 |
136,971 |
135,541 |
128,452 |
119,988 |
123,366 |
131,033 |
125,292 |
118,564 |
128,452 |
125,292 |
Third-party assets under management |
||||||||||||
Retail |
9 |
633,767 |
607,727 |
606,320 |
567,657 |
544,946 |
557,093 |
543,847 |
527,617 |
505,679 |
567,657 |
527,617 |
Institutional and managed & other |
10 |
562,565 |
553,798 |
563,773 |
537,424 |
518,129 |
527,344 |
528,897 |
507,673 |
485,670 |
537,424 |
507,673 |
Total third-party assets under management |
11 |
1,196,332 |
1,161,525 |
1,170,093 |
1,105,081 |
1,063,075 |
1,084,437 |
1,072,744 |
1,035,290 |
991,349 |
1,105,081 |
1,035,290 |
Consolidation adjustments |
12 |
(43,014) |
(41,240) |
(40,540) |
(38,717) |
(36,780) |
(37,536) |
(41,947) |
(40,337) |
(38,725) |
(38,717) |
(40,337) |
Total assets under management ("AUM") |
13 |
1,514,570 |
1,464,801 |
1,470,080 |
1,399,605 |
1,340,141 |
1,366,842 |
1,363,622 |
1,318,561 |
1,269,369 |
1,399,605 |
1,318,561 |
Total assets under administration ("AUA") (4) |
14 |
71,001 |
66,584 |
64,696 |
99,350 |
94,600 |
95,961 |
95,696 |
43,866 |
41,815 |
99,350 |
43,866 |
Total AUMA |
15 |
1,585,571 |
1,531,385 |
1,534,776 |
1,498,955 |
1,434,741 |
1,462,803 |
1,459,318 |
1,362,427 |
1,311,184 |
1,498,955 |
1,362,427 |
Select Constant Currency Measures (3) |
||||||||||||
Underlying net income |
16 |
1,005 |
930 |
|||||||||
Reported net income |
17 |
1,326 |
871 |
|||||||||
Wealth sales & asset management gross flows |
18 |
41,307 |
39,324 |
|||||||||
Net wealth sales & asset management net flows |
19 |
(16,928) |
(9,122) |
|||||||||
AUM |
20 |
1,516,471 |
1,340,141 |
|||||||||
Individual - Protection sales |
21 |
720 |
669 |
|||||||||
Group - Health & Protection sales |
22 |
439 |
374 |
|||||||||
Underlying EPS - diluted |
23 |
1.74 |
1.59 |
|||||||||
Reported EPS - diluted |
24 |
2.28 |
1.48 |
- Certain numbers have been rounded in order to arrive at the number of common shares outstanding at end of period.
- The number of diluted shares outstanding reflect the impact of dilution from SLEECS under IFRS. Where the calculation of diluted EPS has resulted in anti-dilution, the dilutive impact of the SLEECS has been excluded in the number of weighted average number of shares outstanding.
- Represents a non-IFRS financial measure. Refer to the Non-IFRS Financial Measures section on page 1 and the Additional Non-IFRS Financial Measures Glossary in the appendix of this document, or Section N. Non-IFRS Financial Measures of the Company's Q3'24 MD&A.
- Q3'24 includes
$3.1 billion of consolidation adjustments.
3
CONSOLIDATED STATEMENTS OF OPERATIONS |
For the Quarter Ended |
For the Year Ended |
||||||||||
(C$ millions) |
Q3 2024 |
Q2 2024 |
Q1 2024 |
Q4 2023 |
Q3 2023 |
Q2 2023 |
Q1 2023 |
Q4 2022 |
Q3 2022 |
2023 |
2022 |
|
Insurance service result |
||||||||||||
Insurance revenue |
1 |
5,651 |
5,567 |
5,540 |
5,458 |
5,333 |
5,283 |
5,282 |
5,305 |
5,149 |
21,356 |
18,902 |
Insurance service expenses |
2 |
(4,998) |
(4,737) |
(4,840) |
(4,803) |
(4,555) |
(4,528) |
(4,564) |
(4,491) |
(4,269) |
(18,450) |
(16,456) |
Reinsurance contract held net income (expenses) |
3 |
47 |
(24) |
61 |
7 |
(66) |
20 |
(30) |
(63) |
(289) |
(69) |
(153) |
Net insurance service result |
4 |
700 |
806 |
761 |
662 |
712 |
775 |
688 |
751 |
591 |
2,837 |
2,293 |
Investment result |
||||||||||||
Investment result excluding result for account of segregated fund holders: |
||||||||||||
Net investment income (loss) |
5 |
7,540 |
1,272 |
(677) |
11,161 |
(4,824) |
449 |
4,800 |
1,168 |
(2,056) |
11,586 |
(20,580) |
Insurance finance income (expenses) from insurance contracts issued |
6 |
(6,778) |
(786) |
1,376 |
(10,982) |
5,759 |
(81) |
(4,371) |
(640) |
2,105 |
(9,675) |
22,595 |
Insurance finance income (expenses) from reinsurance contracts held |
7 |
122 |
(14) |
9 |
178 |
(144) |
(38) |
63 |
5 |
(143) |
59 |
(440) |
Decrease (increase) in investment contract liabilities |
8 |
(100) |
(102) |
(99) |
(96) |
(88) |
(76) |
(71) |
(50) |
(45) |
(331) |
(152) |
Net investment result excluding result for account of segregated fund holders |
9 |
784 |
370 |
609 |
261 |
703 |
254 |
421 |
483 |
(139) |
1,639 |
1,423 |
Investment result for insurance contracts for account of segregated fund holders: |
||||||||||||
Investment income (loss) on investments for account of segregated fund holders |
10 |
1,213 |
74 |
1,056 |
1,109 |
(362) |
234 |
812 |
1,092 |
(403) |
1,793 |
(2,353) |
Insurance finance income (expenses) |
11 |
(1,213) |
(74) |
(1,056) |
(1,109) |
362 |
(234) |
(812) |
(1,092) |
403 |
(1,793) |
2,353 |
Net investment result for insurance contracts for account of segregated fund holders |
12 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Net investment result |
13 |
784 |
370 |
609 |
261 |
703 |
254 |
421 |
483 |
(139) |
1,639 |
1,423 |
Fee income |
14 |
2,142 |
2,077 |
2,012 |
2,065 |
1,930 |
1,936 |
1,901 |
2,021 |
1,808 |
7,832 |
7,447 |
Other expenses (income) |
||||||||||||
Other income (1) |
15 |
- |
- |
(161) |
- |
- |
(67) |
(102) |
- |
- |
(169) |
- |
Operating expenses and commissions |
16 |
1,798 |
2,205 |
2,187 |
2,086 |
2,004 |
2,023 |
1,882 |
1,995 |
1,911 |
7,995 |
7,092 |
Interest expenses |
17 |
185 |
138 |
159 |
115 |
160 |
142 |
135 |
127 |
119 |
552 |
445 |
Total other expenses (income) |
18 |
1,983 |
2,343 |
2,185 |
2,201 |
2,164 |
2,098 |
1,915 |
2,122 |
2,030 |
8,378 |
7,537 |
Income before income taxes |
19 |
1,643 |
910 |
1,197 |
787 |
1,181 |
867 |
1,095 |
1,133 |
230 |
3,930 |
3,626 |
Less: Income tax expense (benefit) |
20 |
215 |
192 |
261 |
(87) |
244 |
127 |
177 |
(65) |
77 |
461 |
546 |
Total net income |
21 |
1,428 |
718 |
936 |
874 |
937 |
740 |
918 |
1,198 |
153 |
3,469 |
3,080 |
Less: Net income (loss) allocated to the participating account |
22 |
54 |
48 |
55 |
57 |
37 |
51 |
33 |
(16) |
15 |
178 |
83 |
Less: Net income (loss) attributable to non-controlling interest ("NCI") |
23 |
6 |
4 |
43 |
48 |
10 |
9 |
59 |
29 |
9 |
126 |
56 |
Net income - Shareholders |
24 |
1,368 |
666 |
838 |
769 |
890 |
680 |
826 |
1,185 |
129 |
3,165 |
2,941 |
Less: Preferred shareholders' dividends and distributions on other equity instruments |
25 |
20 |
20 |
20 |
20 |
19 |
20 |
20 |
20 |
18 |
79 |
70 |
Reported net income - Common shareholders |
26 |
1,348 |
646 |
818 |
749 |
871 |
660 |
806 |
1,165 |
111 |
3,086 |
2,871 |
Underlying net income (2) |
27 |
1,016 |
1,000 |
875 |
983 |
930 |
920 |
895 |
892 |
949 |
3,728 |
3,369 |
- Refer to the Notes page ii, Adjustments - Acquisition, Integration and Restructuring and Adjustments - other for additional details.
- Represents a non-IFRS financial measure. Refer to the Non-IFRS Financial Measures section on page 1 and the Additional Non-IFRS Financial Measures Glossary in the appendix of this document, or Section N. Non-IFRS Financial Measures of the Company's Q3'24 MD&A.
4
COMMON SHAREHOLDERS' DRIVERS OF EARNINGS ("DOE") - Total |
||||||||||||
Company (1) |
For the Quarter Ended |
For the Year Ended |
||||||||||
(C$ millions) |
Q3 2024 |
Q2 2024 |
Q1 2024 |
Q4 2023 |
Q3 2023 |
Q2 2023 |
Q1 2023 |
Q4 2022 |
Q3 2022 |
2023 |
2022 |
|
Risk adjustment release |
1 |
101 |
104 |
101 |
106 |
114 |
103 |
95 |
105 |
98 |
418 |
392 |
Contractual Service Margin ("CSM") recognized for services provided |
2 |
236 |
226 |
224 |
215 |
184 |
192 |
199 |
192 |
193 |
790 |
760 |
Expected earnings on short-term (group) insurance business |
3 |
421 |
419 |
417 |
407 |
373 |
367 |
378 |
350 |
339 |
1,525 |
1,235 |
Expected insurance earnings |
4 |
758 |
749 |
742 |
728 |
671 |
662 |
672 |
647 |
630 |
2,733 |
2,387 |
Impact of new insurance business |
5 |
(23) |
(13) |
(14) |
(15) |
(12) |
(12) |
(12) |
(31) |
(22) |
(51) |
(91) |
Experience gains (losses) (2) |
6 |
67 |
11 |
(16) |
56 |
81 |
144 |
16 |
110 |
82 |
297 |
80 |
Net insurance service result - Underlying |
7 |
802 |
747 |
712 |
769 |
740 |
794 |
676 |
726 |
690 |
2,979 |
2,376 |
Expected investment earnings |
8 |
245 |
243 |
224 |
230 |
218 |
221 |
217 |
165 |
171 |
886 |
653 |
Credit experience |
9 |
(80) |
(14) |
(27) |
(25) |
(8) |
(4) |
(10) |
(15) |
- |
(47) |
(26) |
Earnings on surplus |
10 |
161 |
159 |
160 |
158 |
155 |
165 |
161 |
118 |
152 |
639 |
491 |
Joint ventures & other |
11 |
81 |
61 |
62 |
64 |
51 |
48 |
69 |
48 |
34 |
232 |
119 |
Net investment results - Underlying |
12 |
407 |
449 |
419 |
427 |
416 |
430 |
437 |
316 |
357 |
1,710 |
1,237 |
Asset Management - underlying |
13 |
457 |
417 |
383 |
460 |
437 |
403 |
377 |
429 |
407 |
1,677 |
1,651 |
Other fee income (2) |
14 |
98 |
84 |
48 |
66 |
38 |
64 |
79 |
55 |
88 |
247 |
298 |
Expenses - other (2)(3) |
15 |
(482) |
(451) |
(479) |
(489) |
(485) |
(500) |
(454) |
(415) |
(368) |
(1,928) |
(1,435) |
Income before taxes - Underlying |
16 |
1,282 |
1,246 |
1,083 |
1,233 |
1,146 |
1,191 |
1,115 |
1,111 |
1,174 |
4,685 |
4,127 |
Income tax (expense) or recovery |
17 |
(232) |
(215) |
(175) |
(203) |
(182) |
(235) |
(191) |
(187) |
(193) |
(811) |
(637) |
Dividends, distributions, NCI (4) |
18 |
(34) |
(31) |
(33) |
(47) |
(34) |
(36) |
(29) |
(32) |
(32) |
(146) |
(121) |
Underlying net income (1) |
19 |
1,016 |
1,000 |
875 |
983 |
930 |
920 |
895 |
892 |
949 |
3,728 |
3,369 |
Add: Non-underlying net income adjustments (1) (post-tax): |
||||||||||||
Market-related impacts |
20 |
29 |
(153) |
(70) |
(193) |
23 |
(220) |
(64) |
224 |
(361) |
(454) |
(21) |
Assumption changes and management actions ("ACMA") |
21 |
36 |
16 |
(7) |
(1) |
35 |
7 |
(5) |
12 |
(131) |
36 |
(168) |
Other adjustments: |
||||||||||||
Management's ownership of MFS shares |
22 |
(10) |
- |
(12) |
(11) |
7 |
(1) |
17 |
27 |
37 |
12 |
115 |
Acquisition, integration and restructuring (5) |
23 |
312 |
(164) |
22 |
(42) |
(89) |
(20) |
(4) |
(86) |
(312) |
(155) |
(492) |
Intangible asset amortization |
24 |
(35) |
(38) |
(36) |
(38) |
(35) |
(26) |
(33) |
(41) |
(23) |
(132) |
(97) |
Other (5) |
25 |
- |
(15) |
46 |
51 |
- |
- |
- |
137 |
(48) |
51 |
165 |
Reported net income - Common shareholders |
26 |
1,348 |
646 |
818 |
749 |
871 |
660 |
806 |
1,165 |
111 |
3,086 |
2,871 |
For the Quarter Ended |
For the Year Ended |
|||||||||||
Q3 2024 |
Q2 2024 |
Q1 2024 |
Q4 2023 |
Q3 2023 |
Q2 2023 |
Q1 2023 |
Q4 2022 |
Q3 2022 |
2023 |
2022 |
||
UNDERLYING NET INCOME BY BUSINESS TYPE (1) - |
||||||||||||
Wealth & asset management |
27 |
474 |
455 |
408 |
439 |
457 |
419 |
411 |
412 |
419 |
1,726 |
1,673 |
Group - Health & Protection |
28 |
345 |
305 |
280 |
365 |
285 |
360 |
303 |
321 |
281 |
1,313 |
963 |
Individual - Protection |
29 |
306 |
347 |
278 |
284 |
297 |
265 |
291 |
231 |
305 |
1,137 |
1,000 |
Corporate expenses & other |
30 |
(109) |
(107) |
(91) |
(105) |
(109) |
(124) |
(110) |
(72) |
(56) |
(448) |
(267) |
Underlying net income |
31 |
1,016 |
1,000 |
875 |
983 |
930 |
920 |
895 |
892 |
949 |
3,728 |
3,369 |
Add: Market-related impacts |
32 |
29 |
(153) |
(70) |
(193) |
23 |
(220) |
(64) |
224 |
(361) |
(454) |
(21) |
ACMA |
33 |
36 |
16 |
(7) |
(1) |
35 |
7 |
(5) |
12 |
(131) |
36 |
(168) |
Other adjustments |
34 |
267 |
(217) |
20 |
(40) |
(117) |
(47) |
(20) |
37 |
(346) |
(224) |
(309) |
Reported net income - Common shareholders |
35 |
1,348 |
646 |
818 |
749 |
871 |
660 |
806 |
1,165 |
111 |
3,086 |
2,871 |
EXCHANGE RATES - Average for the period |
||||||||||||
|
36 |
1.36 |
1.37 |
1.35 |
1.36 |
1.34 |
1.34 |
1.35 |
1.36 |
1.30 |
1.35 |
1.30 |
- The
DOE analysis and Underlying Net Income by Business Type contain non-IFRS financial measures. Refer to the Non-IFRS Financial Measures section on page 1 and the Additional Non-IFRS Financial Measures Glossary in the appendix of this document, or Section N. Non-IFRS Financial Measures of the Company's Q3'24 MD&A. Refer to the Basis of Presentation section on page ii of this document for more information about certain amounts that are presented on a net basis to reflect how the business is managed, compared to a gross basis in the Consolidated Financial Statements. - Effective Q4'23, prior period amounts in the
DOE related to Expenses - other for health, wealth and asset management businesses inCanada have been restated to improve comparability of data over time and with other business units; related amounts in Other fee income and Experience gains (losses) have also been restated accordingly. In addition, effective Q3'23, the Other Fee Income line for theU.S. business segment has been refined to include Group Benefits and Health & Risk Solutions fee income net of corresponding expenses in order to align with the presentation of the Dental business in this line. We have updated prior period amounts to reflect this refinement. - Expenses - other removes non-underlying Other adjustments, including Management's ownership of MFS shares, Acquisition, integration and restructuring, and Intangible asset amortization. Certain Other adjustments - other may also be removed from Other expenses.
- Dividends on preferred shares, distributions on other equity instruments, and non-controlling interests ("Dividends, distributions, NCI").
- Refer to the Notes page ii, Adjustments - Acquisition, Integration and Restructuring and Adjustments - other for additional details.
5
COMMON SHAREHOLDERS' |
For the Quarter Ended - Q3 2024 |
||||||||
($ millions) |
Canadian dollars |
|
|||||||
Asset |
|
|
|
Corporate |
Total |
MFS |
|
||
Management |
Company |
||||||||
Risk adjustment release |
1 |
- |
50 |
9 |
42 |
- |
101 |
- |
6 |
CSM recognized for services provided |
2 |
- |
94 |
18 |
124 |
- |
236 |
- |
14 |
Expected earnings on short-term (group) insurance business |
3 |
- |
163 |
258 |
- |
- |
421 |
- |
188 |
Expected insurance earnings |
4 |
- |
307 |
285 |
166 |
- |
758 |
- |
208 |
Impact of new insurance business |
5 |
- |
(8) |
- |
(15) |
- |
(23) |
- |
- |
Experience gains (losses) (2) |
6 |
- |
78 |
7 |
(15) |
(3) |
67 |
- |
8 |
Net insurance service result - Underlying |
7 |
- |
377 |
292 |
136 |
(3) |
802 |
- |
216 |
Expected investment earnings |
8 |
- |
182 |
49 |
14 |
- |
245 |
- |
32 |
Credit experience |
9 |
- |
(61) |
(14) |
(5) |
- |
(80) |
- |
(10) |
Earnings on surplus |
10 |
- |
57 |
47 |
34 |
23 |
161 |
- |
35 |
Joint ventures & other |
11 |
- |
2 |
11 |
63 |
5 |
81 |
- |
8 |
Net investment results - Underlying |
12 |
- |
180 |
93 |
106 |
28 |
407 |
- |
65 |
Asset Management - underlying |
13 |
457 |
- |
- |
- |
- |
457 |
284 |
- |
Other fee income (2) |
14 |
- |
71 |
11 |
16 |
- |
98 |
- |
7 |
Expenses - other (2)(3) |
15 |
- |
(141) |
(122) |
(82) |
(137) |
(482) |
- |
(86) |
Income before taxes - Underlying |
16 |
457 |
487 |
274 |
176 |
(112) |
1,282 |
284 |
202 |
Income tax (expense) or recovery |
17 |
(99) |
(112) |
(55) |
(6) |
40 |
(232) |
(66) |
(41) |
Dividends, distributions, NCI |
18 |
(14) |
- |
- |
- |
(20) |
(34) |
- |
- |
Underlying net income (1) |
19 |
344 |
375 |
219 |
170 |
(92) |
1,016 |
218 |
161 |
Add: Non-underlying net income adjustments (1) (post-tax): |
|||||||||
Market-related impacts |
20 |
(6) |
47 |
12 |
(57) |
33 |
29 |
- |
9 |
ACMA |
21 |
- |
(34) |
140 |
(74) |
4 |
36 |
- |
104 |
Other adjustments: |
|||||||||
Management's ownership of MFS shares |
22 |
(10) |
- |
- |
- |
- |
(10) |
(8) |
- |
Acquisition, integration and restructuring (4) |
23 |
322 |
- |
(11) |
(5) |
6 |
312 |
- |
(8) |
Intangible asset amortization |
24 |
(6) |
(6) |
(21) |
(2) |
- |
(35) |
- |
(16) |
Other (4) |
25 |
- |
- |
- |
- |
- |
- |
- |
- |
Reported net income - Common shareholders |
26 |
644 |
382 |
339 |
32 |
(49) |
1,348 |
210 |
250 |
COMMON SHAREHOLDERS' |
For the Quarter Ended - Q3 2023 |
||||||||
($ millions) |
Canadian dollars |
|
|||||||
Asset |
|
|
|
Corporate |
Total |
MFS |
|
||
Management |
Company |
||||||||
Risk adjustment release |
27 |
- |
51 |
10 |
54 |
(1) |
114 |
- |
8 |
CSM recognized for services provided |
28 |
- |
80 |
20 |
84 |
- |
184 |
- |
15 |
Expected earnings on short-term (group) insurance business |
29 |
- |
138 |
234 |
1 |
- |
373 |
- |
175 |
Expected insurance earnings |
30 |
- |
269 |
264 |
139 |
(1) |
671 |
- |
198 |
Impact of new insurance business |
31 |
- |
(10) |
- |
(2) |
- |
(12) |
- |
- |
Experience gains (losses) (2) |
32 |
- |
74 |
6 |
2 |
(1) |
81 |
- |
2 |
Net insurance service result - Underlying |
33 |
- |
333 |
270 |
139 |
(2) |
740 |
- |
200 |
Expected investment earnings |
34 |
- |
164 |
36 |
18 |
- |
218 |
- |
28 |
Credit experience |
35 |
- |
(2) |
(6) |
- |
- |
(8) |
- |
(4) |
Earnings on surplus |
36 |
- |
46 |
35 |
40 |
34 |
155 |
- |
28 |
Joint ventures & other |
37 |
- |
2 |
2 |
47 |
- |
51 |
- |
1 |
Net investment results - Underlying |
38 |
- |
210 |
67 |
105 |
34 |
416 |
- |
53 |
Asset Management - underlying |
39 |
437 |
- |
- |
- |
- |
437 |
271 |
- |
Other fee income (2) |
40 |
- |
35 |
4 |
(1) |
- |
38 |
- |
3 |
Expenses - other (2)(3) |
41 |
- |
(148) |
(114) |
(76) |
(147) |
(485) |
- |
(86) |
Income before taxes - Underlying |
42 |
437 |
430 |
227 |
167 |
(115) |
1,146 |
271 |
170 |
Income tax (expense) or recovery |
43 |
(92) |
(92) |
(42) |
(1) |
45 |
(182) |
(64) |
(30) |
Dividends, distributions, NCI |
44 |
(15) |
- |
- |
- |
(19) |
(34) |
- |
- |
Underlying net income (1) |
45 |
330 |
338 |
185 |
166 |
(89) |
930 |
207 |
140 |
Add: Non-underlying net income adjustments (1) (post-tax): |
|||||||||
Market-related impacts |
46 |
(3) |
10 |
36 |
(4) |
(16) |
23 |
- |
30 |
ACMA |
47 |
- |
15 |
(36) |
56 |
- |
35 |
- |
(26) |
Other adjustments: |
|||||||||
Management's ownership of MFS shares |
48 |
7 |
- |
- |
- |
- |
7 |
5 |
- |
Acquisition, integration and restructuring (4) |
49 |
(58) |
5 |
(31) |
(5) |
- |
(89) |
- |
(23) |
Intangible asset amortization |
50 |
(8) |
(3) |
(22) |
(2) |
- |
(35) |
- |
(16) |
Other (4) |
51 |
- |
- |
- |
- |
- |
- |
- |
- |
Reported net income - Common shareholders |
52 |
268 |
365 |
132 |
211 |
(105) |
871 |
212 |
105 |
- The
DOE analysis and Underlying Net Income by Business Type contain non-IFRS financial measures. Refer to the Non-IFRS Financial Measures section on page 1 and the Additional Non-IFRS Financial Measures Glossary in the appendix of this document, or Section N. Non-IFRS Financial Measures of the Company's Q3'24 MD&A. Refer to the Basis of Presentation section on page ii of this document for more information about certain amounts that are presented on a net basis to reflect how the business is managed, compared to a gross basis in the Consolidated Financial Statements. - Effective Q4'23, prior period amounts in the
DOE related to Expenses - other for health, wealth and asset management businesses inCanada have been restated to improve comparability of data over time and with other business units; related amounts in Other fee income and Experience gains (losses) have also been restated accordingly. In addition, effective Q3'23, the Other Fee Income line for theU.S. business segment has been refined to include Group Benefits and Health & Risk Solutions fee income net of corresponding expenses in order to align with the presentation of the Dental business in this line. We have updated prior period amounts to reflect this refinement. - Expenses - other removes non-underlying Other adjustments, including Management's ownership of MFS shares, Acquisition, integration and restructuring, and Intangible asset amortization. Certain Other adjustments - other may also be removed from Other expenses.
- Refer to the Notes page ii, Adjustments - Acquisition, Integration and Restructuring and Adjustments - other for additional details.
6
STATEMENTS OF FINANCIAL POSITION |
At the Quarter Ended |
At the Year Ended |
||||||||||
(C$ millions) |
Q3 2024 |
Q2 2024 |
Q1 2024 |
Q4 2023 |
Q3 2023 |
Q2 2023 |
Q1 2023 |
Q4 2022 |
Q3 2022 |
2023 |
2022 |
|
Assets |
||||||||||||
Cash, cash equivalents and short-term securities |
1 |
11,765 |
11,477 |
11,265 |
13,173 |
11,026 |
10,348 |
11,012 |
11,219 |
11,386 |
13,173 |
11,219 |
Debt securities |
2 |
81,832 |
76,174 |
75,887 |
75,493 |
68,879 |
72,469 |
76,285 |
75,902 |
75,526 |
75,493 |
75,902 |
Equity securities |
3 |
9,398 |
8,420 |
7,750 |
7,138 |
7,080 |
7,187 |
7,590 |
7,148 |
6,740 |
7,138 |
7,148 |
Mortgages and loans |
4 |
57,151 |
55,647 |
54,798 |
54,600 |
51,994 |
52,338 |
53,303 |
51,253 |
51,117 |
54,600 |
51,253 |
Derivative assets |
5 |
1,724 |
1,691 |
1,504 |
2,183 |
1,878 |
2,178 |
1,813 |
2,095 |
2,632 |
2,183 |
2,095 |
Other financial invested assets |
6 |
11,560 |
11,909 |
10,943 |
10,361 |
10,203 |
9,613 |
9,482 |
9,418 |
8,869 |
10,361 |
9,418 |
Financial assets |
7 |
173,430 |
165,318 |
162,147 |
162,948 |
151,060 |
154,133 |
159,485 |
157,035 |
156,270 |
162,948 |
157,035 |
Investment properties |
8 |
9,333 |
9,474 |
9,555 |
9,723 |
9,952 |
10,001 |
10,148 |
10,102 |
10,149 |
9,723 |
10,102 |
Other non-financial invested assets |
9 |
1,769 |
1,697 |
1,713 |
1,657 |
1,752 |
1,683 |
1,676 |
1,652 |
1,651 |
1,657 |
1,652 |
Invested assets |
10 |
184,532 |
176,489 |
173,415 |
174,328 |
162,764 |
165,817 |
171,309 |
168,789 |
168,070 |
174,328 |
168,789 |
Other assets |
11 |
6,981 |
6,922 |
7,475 |
6,462 |
7,601 |
7,409 |
6,829 |
6,442 |
6,690 |
6,462 |
6,442 |
Reinsurance contract held assets |
12 |
5,978 |
5,707 |
5,745 |
5,794 |
5,766 |
5,998 |
6,052 |
6,115 |
6,271 |
5,794 |
6,115 |
Insurance contract assets |
13 |
411 |
203 |
180 |
184 |
208 |
214 |
238 |
75 |
141 |
184 |
75 |
Deferred tax assets |
14 |
4,099 |
3,957 |
3,939 |
3,878 |
3,421 |
3,448 |
3,475 |
3,466 |
3,285 |
3,878 |
3,466 |
Intangible assets |
15 |
5,071 |
5,116 |
5,142 |
5,174 |
5,161 |
4,886 |
5,081 |
4,724 |
5,150 |
5,174 |
4,724 |
|
16 |
9,108 |
9,151 |
9,090 |
8,969 |
8,937 |
8,803 |
8,808 |
8,705 |
8,574 |
8,969 |
8,705 |
Total general fund assets |
17 |
216,180 |
207,545 |
204,986 |
204,789 |
193,858 |
196,575 |
201,792 |
198,316 |
198,181 |
204,789 |
198,316 |
Investments for account of segregated fund holders |
18 |
145,072 |
136,971 |
135,541 |
128,452 |
119,988 |
123,366 |
131,033 |
125,292 |
118,564 |
128,452 |
125,292 |
Total assets |
19 |
361,252 |
344,516 |
340,527 |
333,241 |
313,846 |
319,941 |
332,825 |
323,608 |
316,745 |
333,241 |
323,608 |
Liabilities and equity |
||||||||||||
Liabilities |
||||||||||||
Insurance contract liabilities excluding those for account of segregated fund holders |
20 |
144,300 |
136,540 |
134,909 |
135,669 |
124,873 |
129,103 |
134,230 |
131,294 |
130,660 |
135,669 |
131,294 |
Reinsurance contract held liabilities |
21 |
1,690 |
1,480 |
1,536 |
1,623 |
1,543 |
1,612 |
1,734 |
1,603 |
1,820 |
1,623 |
1,603 |
Investment contract liabilities |
22 |
11,769 |
11,755 |
11,757 |
11,672 |
11,344 |
11,065 |
10,967 |
10,728 |
10,429 |
11,672 |
10,728 |
Derivative liabilities |
23 |
1,567 |
1,774 |
1,703 |
1,311 |
2,541 |
1,628 |
1,915 |
2,351 |
3,186 |
1,311 |
2,351 |
Deferred tax liabilities |
24 |
285 |
277 |
278 |
281 |
305 |
524 |
512 |
468 |
568 |
281 |
468 |
Other liabilities |
25 |
24,264 |
23,892 |
23,779 |
23,655 |
23,108 |
22,572 |
22,147 |
22,109 |
22,133 |
23,655 |
22,109 |
Senior debentures - innovative capital instruments |
26 |
200 |
200 |
200 |
200 |
200 |
200 |
200 |
200 |
200 |
200 |
200 |
Subordinated debt |
27 |
6,177 |
6,926 |
6,179 |
6,178 |
6,177 |
6,679 |
6,677 |
6,676 |
7,075 |
6,178 |
6,676 |
Total general fund liabilities |
28 |
190,252 |
182,844 |
180,341 |
180,589 |
170,091 |
173,383 |
178,382 |
175,429 |
176,071 |
180,589 |
175,429 |
Insurance contract liabilities for account of segregated fund holders |
29 |
20,192 |
19,202 |
19,654 |
19,041 |
18,377 |
19,032 |
23,622 |
23,139 |
22,070 |
19,041 |
23,139 |
Investment contract liabilities for account of segregated fund holders |
30 |
124,880 |
117,769 |
115,887 |
109,411 |
101,611 |
104,334 |
107,411 |
102,153 |
96,494 |
109,411 |
102,153 |
Total liabilities |
31 |
335,324 |
319,815 |
315,882 |
309,041 |
290,079 |
296,749 |
309,415 |
300,721 |
294,635 |
309,041 |
300,721 |
Equity |
||||||||||||
Issued share capital and contributed surplus |
32 |
10,550 |
10,572 |
10,643 |
10,660 |
10,642 |
10,671 |
10,664 |
10,640 |
10,643 |
10,660 |
10,640 |
Shareholders' retained earnings and accumulated other comprehensive income ("OCI") |
33 |
14,678 |
13,470 |
13,386 |
12,922 |
12,581 |
12,029 |
12,310 |
11,889 |
11,132 |
12,922 |
11,889 |
Total shareholders' equity |
34 |
25,228 |
24,042 |
24,029 |
23,582 |
23,223 |
22,700 |
22,974 |
22,529 |
21,775 |
23,582 |
22,529 |
Equity in the participating account |
35 |
621 |
567 |
510 |
457 |
397 |
354 |
303 |
268 |
271 |
457 |
268 |
NCI equity |
36 |
79 |
92 |
106 |
161 |
147 |
138 |
133 |
90 |
64 |
161 |
90 |
Total equity |
37 |
25,928 |
24,701 |
24,645 |
24,200 |
23,767 |
23,192 |
23,410 |
22,887 |
22,110 |
24,200 |
22,887 |
Total liabilities and equity |
38 |
361,252 |
344,516 |
340,527 |
333,241 |
313,846 |
319,941 |
332,825 |
323,608 |
316,745 |
333,241 |
323,608 |
EXCHANGE RATES - Period end rates |
||||||||||||
|
39 |
1.35 |
1.37 |
1.35 |
1.32 |
1.36 |
1.32 |
1.35 |
1.35 |
1.38 |
1.32 |
1.35 |
7
Attachments
Disclaimer
Earnings news release (pa e q324 earnings)
LINCOLN NATIONAL INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lincoln National Corporation – LNC
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News